Short communication · 1 Oct 2025
CommentaryPublished 1 Sep 2022
Efficacy of Etoposide Against Doxorubicin Induced Cardiotoxicity in H9c2 Cardiomyoblasts
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Doxorubicin (DOX), a broadly utilized anticancer medication, has been related with cardiotoxicity. As of late, DOX-prompted cardiotoxicity has been ascribed to topoisomerase II (TOPII)-β articulation and movement. In our examination, we researched the impact of restraining TOPII in weakening the DOX actuated cardiotoxicity. H9c2 cardiomyoblasts were treated with 1 or 2 μM DOX ETO. Cardiotoxicity was surveyed by inspecting cell reasonability utilizing the MTT measure, hypertrophy of gem violet recolored cardiomyoblasts and ROS creation. DOX instigated a portion subordinate expansion in cardiotoxicity as demonstrated by the huge decrease in cell suitability DOX versus 100% control.
Subjects
EducationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Anatomy & Physiology: Current Research.
Opinion · 1 Oct 2025
Comparative Anatomy in Evolutionary and Biomedical Research
Opinion · 1 Oct 2025
Endocrine Regulation of Metabolism: Current Advances and Future Directions
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnatomy & Physiology: Current Research
- SubjectEducation
- BylineArticles whose byline prints “Sara Shabana”
